Microscopic Raman illustrating antitumor enhancement effects by the combination drugs of γ-secretase inhibitor and cisplatin on osteosarcoma cells

J Biophotonics. 2022 Dec;15(12):e202200189. doi: 10.1002/jbio.202200189. Epub 2022 Sep 13.

Abstract

By using Raman microspectroscopy, it aims to elucidate the cellular variations caused by the combination drug of γ-secretase inhibitor (DAPT) and cisplatin in osteosarcoma (OS) cells. Illustrated by the obtained results of spectral analysis, the intracellular composition significantly changed after combined drug actions compared to the solo DAPT treatment, indicating the synergistic effect of DAPT combined with cisplatin on OS cells. Meanwhile, multivariate curve resolution-alternating least squares (MCR-ALS) algorithm was utilized to address the biochemical constitution changes in all investigated groups including the untreated (UT), DAPT (40D) and combined drug (40D + 20C) treated cells. K-means cluster and univariate imaging were both utilized to visualize the changes in subcellular morphology and biochemical distribution. The presented study provides a unique understanding on the cellular responses to DAPT combined with cisplatin from the natural biochemical perspectives, and laids an experimental foundation for exploring the therapeutic strategies of other combined anticancer drugs in cancer cell model.

Keywords: Raman microspelayctroscopy; cisplatin; combination drugs; multivariate curve resolution-alternating least squares; osteosarcoma cells; γ-secretase inhibitor (DAPT).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid Precursor Protein Secretases
  • Antinematodal Agents / therapeutic use
  • Bone Neoplasms* / drug therapy
  • Bone Neoplasms* / pathology
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use
  • Humans
  • Osteosarcoma* / drug therapy
  • Osteosarcoma* / pathology
  • Platelet Aggregation Inhibitors / therapeutic use

Substances

  • Amyloid Precursor Protein Secretases
  • Cisplatin
  • Platelet Aggregation Inhibitors
  • Antinematodal Agents